Shaomin Hu Selected Research

Estrogen Receptors

1/2018

Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaomin Hu Research Topics

Disease

4	Neoplasms (Cancer) 01/2021 - 08/2012
3	Infections 07/2015 - 11/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2019
2	Schistosomiasis (Bilharziasis) 10/2009 - 10/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Melanoma (Melanoma, Malignant) 01/2020
1	Adenoma (Adenomas) 04/2019
1	Stomach Neoplasms (Stomach Cancer) 04/2019
1	Focal Nodular Hyperplasia 04/2019
1	Cholangiocarcinoma 04/2019
1	Leukemia 04/2019
1	Lymphoma (Lymphomas) 04/2019
1	Carcinogenesis 04/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2018
1	Carcinoma (Carcinomatosis) 01/2018
1	Endometrioid Carcinoma 01/2018
1	Hypersensitivity (Allergy) 09/2014
1	Atopic Dermatitis (Atopic Eczema) 09/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2014
1	Inflammation (Inflammations) 04/2012
1	Reinfection 11/2011

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 07/2015 - 10/2008
3	LigandsIBA 09/2014 - 11/2011
2	Immunoglobulin A (IgA)IBA 07/2015 - 11/2011
2	Chemokine ReceptorsIBA 09/2014 - 11/2011
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	pembrolizumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	NivolumabIBA 01/2020
1	SpectrinIBA 04/2019
1	Protein Isoforms (Isoforms)IBA 04/2019
1	Estrogen ReceptorsIBA 01/2018
1	AntibodiesIBA 01/2018
1	AntigensIBA 04/2012
1	Proteins (Proteins, Gene)FDA Link 04/2012
1	CytokinesIBA 04/2012
1	ChemokinesIBA 04/2012
1	Biological ProductsIBA 10/2009

Therapy/Procedure

2	Immunotherapy 01/2021 - 01/2020